Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1991 Apr 1;275(Pt 1):151–158. doi: 10.1042/bj2750151

Biosynthesis of heparin. Use of Escherichia coli K5 capsular polysaccharide as a model substrate in enzymic polymer-modification reactions.

M Kusche 1, H H Hannesson 1, U Lindahl 1
PMCID: PMC1150026  PMID: 1902083

Abstract

A capsular polysaccharide from Escherichia coli K5 was previously found to have the same structure, [-(4)beta GlcA(1)----(4)alpha GlcNAc(1)-]n, as that of the non-sulphated precursor polysaccharide in heparin biosynthesis [Vann, Schmidt, Jann & Jann (1981) Eur. J. Biochem. 116, 359-364]. The K5 polysaccharide was N-deacetylated (by hydrazinolysis) and N-sulphated, and was then incubated with detergent-solubilized enzymes from a heparin-producing mouse mastocytoma, in the presence of adenosine 3'-phosphate 5'-phospho[35S] sulphate ([35S]PAPS). Structural analysis of the resulting 35S-labelled polysaccharide revealed the formation of all the major disaccharide units found in heparin. The identification of 2-O-[35S]sulphated IdoA (L-iduronic acid) as well as 6-O-[35S]sulphated GlcNSO3 units demonstrated that the modified K5 polysaccharide served as a substrate in the hexuronosyl C-5-epimerase and the major O-sulphotransferase reactions involved in the biosynthesis of heparin. The GlcA units of the native (N-acetylated) E. coli polysaccharide were attacked by the epimerase only when PAPS was present in the incubations, whereas those of the chemically N-sulphated polysaccharide were epimerized also in the absence of PAPS, in accord with the notion that N-sulphate groups are required for epimerization. With increasing concentrations of PAPS, the mono-O-sulphated disaccharide unit-IdoA(2-OSO3)-GlcNSO3- was progressively converted into the di-O-sulphated species -IdoA(2-OSO3)-GlcNSO3(6-OSO3)-. A small proportion of the 35S-labelled polysaccharide was found to bind with high affinity to the proteinase inhibitor antithrombin. This proportion increased with increasing concentration of PAPS up to a level corresponding to approximately 1-2% of the total incorporated 35S. The solubilized enzymes thus catalysed all the reactions required for the generation of functional antithrombin-binding sites.

Full text

PDF
151

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atha D. H., Lormeau J. C., Petitou M., Rosenberg R. D., Choay J. Contribution of monosaccharide residues in heparin binding to antithrombin III. Biochemistry. 1985 Nov 5;24(23):6723–6729. doi: 10.1021/bi00344a063. [DOI] [PubMed] [Google Scholar]
  2. BITTER T., MUIR H. M. A modified uronic acid carbazole reaction. Anal Biochem. 1962 Oct;4:330–334. doi: 10.1016/0003-2697(62)90095-7. [DOI] [PubMed] [Google Scholar]
  3. Bienkowski M. J., Conrad H. E. Structural characterization of the oligosaccharides formed by depolymerization of heparin with nitrous acid. J Biol Chem. 1985 Jan 10;260(1):356–365. [PubMed] [Google Scholar]
  4. Bäckström G., Hök M., Lindahl U., Feingold D. S., Malmström A., Rodén L., Jacobsson I. Biosynthesis of heparin. Assay and properties of the microsomal uronosyl C-5 epimerase. J Biol Chem. 1979 Apr 25;254(8):2975–2982. [PubMed] [Google Scholar]
  5. Enerbäck L., Kolset S. O., Kusche M., Hjerpe A., Lindahl U. Glycosaminoglycans in rat mucosal mast cells. Biochem J. 1985 Apr 15;227(2):661–668. doi: 10.1042/bj2270661. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. FURTH J., HAGEN P., HIRSCH E. I. Transplantable mastocytoma in the mouse containing histamine, heparin, 5-hydroxytryptamine. Proc Soc Exp Biol Med. 1957 Aug-Sep;95(4):824–828. doi: 10.3181/00379727-95-23375. [DOI] [PubMed] [Google Scholar]
  7. Fedarko N. S., Conrad H. E. A unique heparan sulfate in the nuclei of hepatocytes: structural changes with the growth state of the cells. J Cell Biol. 1986 Feb;102(2):587–599. doi: 10.1083/jcb.102.2.587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Hök M., Lindahl U., Hallén A., Bäckström G. Biosynthesis of heparin. Studies on the microsomal sulfation process. J Biol Chem. 1975 Aug 10;250(15):6065–6071. [PubMed] [Google Scholar]
  9. Hök M., Riesenfeld J., Lindahl U. N-[3H]Acetyl-labeling, a convenient method for radiolabeling of glycosaminoglycans. Anal Biochem. 1982 Jan 15;119(2):236–245. doi: 10.1016/0003-2697(82)90580-2. [DOI] [PubMed] [Google Scholar]
  10. Ishihara M., Fedarko N. S., Conrad H. E. Transport of heparan sulfate into the nuclei of hepatocytes. J Biol Chem. 1986 Oct 15;261(29):13575–13580. [PubMed] [Google Scholar]
  11. Jacobsson I., Hök M., Pettersson I., Lindahl U., Larm O., Wirén E., von Figura K. Identification of N-sulphated disaccharide units in heparin-like polysaccharides. Biochem J. 1979 Apr 1;179(1):77–87. doi: 10.1042/bj1790077. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jacobsson I., Lindahl U. Biosynthesis of heparin. Concerted action of late polymer-modification reactions. J Biol Chem. 1980 Jun 10;255(11):5094–5100. [PubMed] [Google Scholar]
  13. Jacobsson I., Lindahl U., Jensen J. W., Rodén L., Prihar H., Feingold D. S. Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem. 1984 Jan 25;259(2):1056–1063. [PubMed] [Google Scholar]
  14. Kusche M., Bäckström G., Riesenfeld J., Petitou M., Choay J., Lindahl U. Biosynthesis of heparin. O-sulfation of the antithrombin-binding region. J Biol Chem. 1988 Oct 25;263(30):15474–15484. [PubMed] [Google Scholar]
  15. Kusche M., Lindahl U. Biosynthesis of heparin. O-sulfation of D-glucuronic acid units. J Biol Chem. 1990 Sep 15;265(26):15403–15409. [PubMed] [Google Scholar]
  16. Kusche M., Torri G., Casu B., Lindahl U. Biosynthesis of heparin. Availability of glucosaminyl 3-O-sulfation sites. J Biol Chem. 1990 May 5;265(13):7292–7300. [PubMed] [Google Scholar]
  17. LEVY L., PETRACEK F. J. Chemical and pharmacological studies on N-resulfated heparin. Proc Soc Exp Biol Med. 1962 Apr;109:901–905. doi: 10.3181/00379727-109-27372. [DOI] [PubMed] [Google Scholar]
  18. Lidholt K., Riesenfeld J., Jacobsson K. G., Feingold D. S., Lindahl U. Biosynthesis of heparin. Modulation of polysaccharide chain length in a cell-free system. Biochem J. 1988 Sep 1;254(2):571–578. doi: 10.1042/bj2540571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lindahl U., Thunberg L., Bäckström G., Riesenfeld J., Nordling K., Björk I. Extension and structural variability of the antithrombin-binding sequence in heparin. J Biol Chem. 1984 Oct 25;259(20):12368–12376. [PubMed] [Google Scholar]
  20. Navia J. L., Riesenfeld J., Vann W. F., Lindahl U., Rodén L. Assay of N-acetylheparosan deacetylase with a capsular polysaccharide from Escherichia coli K5 as substrate. Anal Biochem. 1983 Nov;135(1):134–140. doi: 10.1016/0003-2697(83)90741-8. [DOI] [PubMed] [Google Scholar]
  21. Pejler G., Bäckström G., Lindahl U., Paulsson M., Dziadek M., Fujiwara S., Timpl R. Structure and affinity for antithrombin of heparan sulfate chains derived from basement membrane proteoglycans. J Biol Chem. 1987 Apr 15;262(11):5036–5043. [PubMed] [Google Scholar]
  22. Petitou M., Duchaussoy P., Lederman I., Choay J., Sinaÿ P. Binding of heparin to antithrombin III: a chemical proof of the critical role played by a 3-sulfated 2-amino-2-deoxy-D-glucose residue. Carbohydr Res. 1988 Aug 15;179:163–172. doi: 10.1016/0008-6215(88)84116-8. [DOI] [PubMed] [Google Scholar]
  23. Riesenfeld J., Hök M., Lindahl U. Biosynthesis of heparin. Concerted action of early polymer-modification reactions. J Biol Chem. 1982 Jan 10;257(1):421–425. [PubMed] [Google Scholar]
  24. Shaklee P. N., Conrad H. E. Hydrazinolysis of heparin and other glycosaminoglycans. Biochem J. 1984 Jan 1;217(1):187–197. doi: 10.1042/bj2170187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Shively J. E., Conrad H. E. Nearest neighbor analysis of heparin: identification and quantitation of the products formed by selective depolymerization procedures. Biochemistry. 1976 Sep 7;15(18):3943–3950. doi: 10.1021/bi00663a006. [DOI] [PubMed] [Google Scholar]
  26. Thunberg L., Bäckström G., Lindahl U. Further characterization of the antithrombin-binding sequence in heparin. Carbohydr Res. 1982 Mar 1;100:393–410. doi: 10.1016/s0008-6215(00)81050-2. [DOI] [PubMed] [Google Scholar]
  27. Vann W. F., Schmidt M. A., Jann B., Jann K. The structure of the capsular polysaccharide (K5 antigen) of urinary-tract-infective Escherichia coli 010:K5:H4. A polymer similar to desulfo-heparin. Eur J Biochem. 1981 May 15;116(2):359–364. doi: 10.1111/j.1432-1033.1981.tb05343.x. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES